Drug Trial Radar · NCT00683137
Analgesic Efficacy And Safety of Valdecoxib For Treatment Of Post-Surgical Pain From Bunionectomy Surgery
Last checked: Nov 20, 2026Latest source record: May 23, 2008 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
450
Actual
Start
Oct 2002
Primary completion
Not stated
Study completion Feb 2003
Sponsor
- Lead sponsor
- PfizerPfizer (PFE)
- Sponsor type
- Industry
- First posted
- May 23, 2008
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The study was done to evaluate the pain relief and safety of 2 valdecoxib doses compared to placebo in patients with moderate or severe pain following bunionectomy surgery, and to evaluate the effect of the 2 valdecoxib doses compared to placebo on health outcome measures and on the occurrence of opioid related symptoms.
Conditions
- Pain
- Hallux Valgus
Interventions
valdecoxibDrug
valdecoxib 40 mg tablet by mouth followed by a valdecoxib 20 mg tablet by mouth after 1 to 12 hours of the initial dose on Day 1 then a valdecoxib 20 mg tablet by mouth once daily on Days 2 through 5
valdecoxibDrug
valdecoxib 40 mg tablet by mouth followed by a valdecoxib 20 mg tablet by mouth after 1 to 12 hours of the initial dose on Day 1 then a valdecoxib 20 mg tablet by mouth twice daily on Days 2 through 5
valdecoxib/placeboDrug
valdecoxib 40 mg tablet by mouth followed by a valdecoxib 20 mg tablet by mouth after 1 to 12 hours of the initial dose on Day 1 then placebo on Days 2 through 5
Primary outcomes
What the sponsor says the trial is designed to measure.
- Patient's Global Evaluation of Study MedicationTime frame: Day 2 and Day 3
- Summed Pain Intensity (SPI) (categorical) through 24 hoursTime frame: Day 2 and Day 3
Locations
89 sites in 1 country. Site status is shown where the registry gives one.
Pfizer Investigational Site
Chandler, Arizona
Pfizer Investigational Site
Glendale, Arizona
Pfizer Investigational Site
Glendale, Arizona
Pfizer Investigational Site
Mesa, Arizona
Pfizer Investigational Site
Phoenix, Arizona
Pfizer Investigational Site
Phoenix, Arizona
Pfizer Investigational Site
Phoenix, Arizona
Pfizer Investigational Site
Phoenix, Arizona
Pfizer Investigational Site
Phoenix, Arizona
Pfizer Investigational Site
Phoenix, Arizona
Pfizer Investigational Site
National City, California
Pfizer Investigational Site
San Diego, California
Pfizer Investigational Site
San Diego, California
Pfizer Investigational Site
San Diego, California
Pfizer Investigational Site
San Diego, California
Pfizer Investigational Site
Milford, Connecticut
Pfizer Investigational Site
New Haven, Connecticut
Pfizer Investigational Site
New Haven, Connecticut
Pfizer Investigational Site
Cooper City, Florida
Pfizer Investigational Site
Cutler Ridge, Florida
Pfizer Investigational Site
Fort Lauderdale, Florida
Pfizer Investigational Site
Fort Lauderdale, Florida
Pfizer Investigational Site
Hallandale, Florida
Pfizer Investigational Site
Hollywood, Florida
Pfizer Investigational Site
Hollywood, Florida
Pfizer Investigational Site
Miami, Florida
Pfizer Investigational Site
New Port Richey, Florida
Pfizer Investigational Site
New Port Richey, Florida
Pfizer Investigational Site
New Port Richey, Florida
Pfizer Investigational Site
Pembroke Pines, Florida
Pfizer Investigational Site
Pembroke Pines, Florida
Pfizer Investigational Site
Port Richey, Florida
Pfizer Investigational Site
South Miami, Florida
Pfizer Investigational Site
Spring Hill, Florida
Pfizer Investigational Site
Addison, Illinois
Pfizer Investigational Site
Elk Grove Village, Illinois
Pfizer Investigational Site
Peoria, Illinois
Pfizer Investigational Site
Peoria, Illinois
Pfizer Investigational Site
Peoria, Illinois
Pfizer Investigational Site
Evansville, Indiana
Showing 40 of 89 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.